SUMMARY A topically applied rubifacient delivered by aerosol (Deep-Heat) was studied. After spray application to the forearms of volunteers, without massage, the erythema produced was measured by thermography and correlated with the concentration of 2 salicylate components of the mixture found in local and systemic venous blood. Maximum erythema occurred at about 30 minutes, while blood salicylate levels were maximal between 20 and 30 minutes after application. Methyl salicylate was absorbed before ethyl salicylate. Over the time period of the erythematous response oxygen levels in local venous blood were raised. Finally, platelets collected from venous blood draining from the sprayed site, when induced to clump by the addition of arachidonic acid in an aggregometer, showed increased resistance to clumping when compared with control cells. The mechanism of these observed phenomena and the mode of action of the constituents of Deep-Heat are discussed.
The British National Formulary lists 26 preparations under the heading of rubifacients.' These mixtures are normally applied to and rubbed into the skin over an affected part, and are used by the public to treat muscular aches and pains. They are generally acknowledged to act by counterirritancy, but there is no evidence to suggest that they act on any fundamental disease process. Indeed it is probable that the act of rubbing is an important part of their effective mechanism.
In spite of the lack of proved efficacy of these preparations patients with clinically defined rheumatoid arthritis, treated by a rheumatologist with oral anti-inflammatory drugs, superimposed rubs and linaments on to this conventional treatment by choice,2 and there is evidence that this practice is normal. 3 The majority of rubifacients contain a mixture of substances to achieve a number of effects when rubbed into the skin: an agent to produce a 'medical smell', an agent to produce an erythematous reaction and irritant response from the skin, and an antiinflammatory agent, normally a salicylate. The combination produces an erythema and irritation which is appreciated as a sensation of warmth. This study used a preparation delivered by aerosol which avoided the need to rub the skin. Thus we did not mechanically alter the skin by application of the rubifacient. We have attempted to show whether any constituents of the applied mixture were systemically absorbed and, if so, to measure the time course of this effect compared with other pharmacological effects. Because of the recognised effect of salicylate on the prostaglandin system of platelets, an action on these cells was chosen to demonstrate an effect at the cellular level. We did not attempt to demonstrate any beneficial clinical effect of application on inflamed or painful tissue.
Materials and methods
The subjects used in this study were volunteers aged between 20 and 40 years. They had not taken aspirin or other anti-inflammatory medicines during 2 weeks prior to the study.
Rubifacient formulation (Deep-Heat). The rubifacient mixture was produced in an aerosol can. The commercial form of the preparation was used which contained the following ingredients:
Methyl nicotinate 1-6% w/w 2-Hydroxyethyl salicylate 5 6 Blood was collected as previously described (9 ml blood added to 1 ml citrate) and centrifuged at 200g for 10 minutes. The platelet rich plasma (PRP) was aspirated and stored at room temperature. Platelet aggregability was then measured by taking a 200 Al aliquot of PRP, which was stirred at 1 100 rpm at 3TC in a plastic tube in a Malin dual channel aggregometer. Arachidonic acid (about 0 4 mM) was added to achieve a threshold concentration which caused platelets to clump. Platelets collected after spraying a forearm with Deep-Heat were aggregated by this method, and the amount of arachidonic acid required to achieve aggregation was compared with the threshold value.
Venous blood oxygen. Oxygen in venous blood was measured using an Instrumentation Laboratories 113 blood gas analyser with an oxygen electrode. Blood from both arms of 2 volunteers was taken for both local and systemic measurements.
Results
When the anterior aspect of the right forearm was sprayed with a small volume of Deep-Heat (500,ul), a visible erythematous skin reaction developed within approximately 10 minutes. The reaction was measured by thermography, and a typical time profile of the erythema is shown in Fig. 1 . The initial fall in the index was the result of cooling owing to evaporation of aerosol vehicle from the skin.
Concurrently, blood taken from the right antecubital fossa was assayed for ethyl and methyl salicylate to show the extent of local absorption of these compounds. The absorption profile of both these constituents in local venous blood drained from the sprayed site was similar to the time course of the erythematous response.
To assess the systemic blood levels achieved by the salicylate components of the spray the right forearm of one subject was completely wetted with the aerosol, then blood was taken from both the right and left antecubital fossae for the next 90 minutes. The blood was assayed for ethyl and methyl salicylate. The result for one volunteer is shown in Fig. 2,and (Fig. 3) . Deep-Heat was tested for its capacity to alter the clumping of platelets. The right forearm of volunteers was sprayed with Deep-Heat and the anterior surface completely wetted. Venous blood samples were then withdrawn from the right antecubital fossa and the harvested platelets tested for their capacity to clump in the presence of arachidonic acid (AA) in an in-vitro test. The results obtained (Fig. 4) suggest that the platelets collected from such blood were made more resistant to AA induced clumping, but only for a short time, the maximum effect being reached at 15 minutes after application of the spray. The effect was not seen in platelets from venous blood from the opposite, untreated arm.
Discussion
Rubifacient preparations are traditional mixtures. O0042b0-049
They usually contain salicylates and other substances that cause a feeling of warmth and wellbeing when they are applied to the skin. Their effect on muscle or joint pain is difficult to quantitate, but some evidence exists that they do relieve rheumatic pain.7 If their popularity with the public is used as a gauge, they are successful medicines, with a market in the UK estimated to be worth £7m. However, they are not formally used to treat joint or muscle pain.
state that massage is not necessary, and we relied purely on the ingredients of the mixture to achieve an effect. It is difficult to know which component of the mixture caused the changes that have been --\ B -........ measured; probably nicotinate was responsible for enhanced by hydrated skin,"
" and its effect is thus modified by skin temperature and hydration. We observed that the erythema produced was less when the skin was cold and that the initial erythema was perifollicular.
Increase in the oxygen concentration in venous blood after application of Deep-Heat may have been due to the creation of shunts between capillaries and venules by the vasodilatatory action of nicotinate, causing the mixing of arteriolar and venous blood. Alternatively, nicotinate does have the direct capacity to reoxygenate reduced haemoglobin, an I/) . I'(4) action involving nicotinamide adenine dinucleotide (4) , (4) (NAD),12 which has been used to rejuvenate butcher's meat. The increase in oxygen concentration shown in Fig. 3 telets were induced to clump in an the levels detected were at the limit of the assay. by the addition ofarachidonic acid. The Figure   The premise that these salicylates, once absorbed, ?unt of arachidonic acid required to induce may affect the prostaglandin system was apparently r the arm was sprayed at zero time. Numbers demonstrated. Fig. 4 shows the apparent increased r ofsubjects tested at each point. Bars =SEM.
resistance to clumping of platelets taken from venous Some observations on the pharmacology of 'deep-heat', a topical rubifacient 415 mechanism by which this happened. This phenomenon was shown only in platelets harvested from local blood. However, salicylate is a poor inhibitor of cyclo-oxygenase, and it may be that resistance to clumping was caused by a different mechanism, for instance by the release of prostacyclin, a potent inhibitor of platelet aggregation, from blood vessel walls,"5 perhaps by the vasodilatatory effect of the applied nicotinate.
None of the pharmacological effects described here may contribute to the action of this or any other rubifacient in the treatment of soft tissue or joint pain, but the combination of counterirritancy, increased local blood flow owing to blood vessel dilatation, enhanced oxygen concentration in local venous blood, and an antiaggregatory effect on platelets would suggest an anti-inflammatory action. All these effects seem to be local phenomena restricted to the treated site and we have no evidence that structures deeper than the skin are affected or that there was any systemic effect. However, the changes observed were real pharmacological effects, illustrating that this type of medicine is not therapeutically inactive and may demonstrate useful pharmacological principles.
